Garfield Alastair
SEC insider (Form 3/4/5 filer). CIK 0002027261. Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM). 15 reported Form 4/5 transactions since Sep 2024; latest on Aug 13, 2026. Located in BOSTON, MA.
Companies Garfield Alastair has filed insider reports for
- RHYTHM PHARMACEUTICALS, INC. (RYTM): Officer, Chief Scientific Officer
Garfield Alastair
CIK: 0002027261
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RHYTHM PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Aug 13, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect2K shares at avg. $116.11$233K - Aug 13, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect1.6K shares at avg. $117.08$182K - Aug 13, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect3.4K shares at avg. $118.28$402K - Aug 13, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect800 shares at avg. $119.17$95K - Jul 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect4.4K shares- - Jul 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Tax PaymentDirect2.2K shares at avg. $110.41$237K - Feb 11, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectStock Options (Right to Buy)
25K shares- - Feb 11, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
16.7K shares- - Feb 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Tax PaymentDirect2K shares at avg. $108.99$221K - Feb 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect6.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 13, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 2,007 | $116.11 | $233,031 | Direct |
| Aug 13, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 1,556 | $117.08 | $182,170 | Direct |
| Aug 13, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 3,400 | $118.28 | $402,167 | Direct |
| Aug 13, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 800 | $119.17 | $95,335 | Direct |
| Jul 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 4,445 | - | $0 | Direct |
| Jul 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Tax Payment | 2,150 | $110.41 | $237,382 | Direct |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Stock Options (Right to Buy) | 25,000 | - | - | Direct |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Restricted Stock Units | 16,650 | - | - | Direct |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Tax Payment | 2,026 | $108.99 | $220,814 | Direct |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 6,663 | - | $0 | Direct |
1-10 of 15 transactions